Sources | Names Used |
---|---|
CTRPv2 | doxorubicin:navitoclax (2:1 mol/mol) |
PharmacoGx | doxorubicin:navitoclax (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | KPNA7 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.001 |
mRNA | GPATCH8 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
mRNA | SLC35D2 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.001 |
mRNA | HERC4 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.001 |
mRNA | FAF1 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
mRNA | TAF13 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
mRNA | XXYLT1 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
mRNA | LUC7L3 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
mRNA | REEP2 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
mRNA | KRT73 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.001 |